SCM
INBX icon

Sterling Capital Management’s Inhibrx INBX Stock Holding History

Sterling Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.78K Sell
61
-241
-80% -$24.1K ﹤0.01% 2533
2026
Q1 		$20.3K Sell
302
-226
-43% -$16.8K ﹤0.01% 2023
2025
Q4 		$41.7K Sell
528
-97
-16% -$6.61K ﹤0.01% 1863
2025
Q3 		$21.1K Buy
625
+380
+155% +$9.36K ﹤0.01% 2110
2025
Q2 		$3.5K Buy
245
+156
+175% +$2.02K ﹤0.01% 2709
2025
Q1 		$1.25K Sell
89
-69
-44% -$937 ﹤0.01% 2741
2024
Q4 		$2.43K Buy
158
+152
+2,533% +$2.31K ﹤0.01% 2728
2024
Q3 		$94 Buy
+6
New +$84 ﹤0.01% 3195

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sterling Capital Management's INBX Position: Q2 2026 in Review

Sterling Capital Management reduced its Inhibrx (INBX) stake by 80% in Q2 2026, selling an estimated $24.1K and leaving 61 shares worth $5.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Sterling Capital Management first reported a position in INBX in Q3 2024 and has held it in 8 quarters since. The position peaked at $41.7K in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Sterling Capital Management held 61 shares of Inhibrx worth $5.78K as of Q2 2026.
  • Sterling Capital Management sold 241 Inhibrx shares in Q2 2026, an estimated $24.1K.
  • Inhibrx made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2533 holding.
  • Sterling Capital Management first reported a position in Inhibrx in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Inhibrx position peaked at $41.7K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.